Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Cushing's Disease: full-pipeline trial registry
3 of 6 indexed Cushing's Disease trials are currently recruiting.
Corpus placement: #2,866 of 28,707 conditions by registered trial count.
6 US clinical trials · 3 currently recruiting · #2,866 of 28,707 conditions by registered trial count
Cushing's Disease: 6 US clinical trials tracked, 3 recruiting.
Cushing's Disease is the subject of 6 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 2 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is Novartis Pharmaceuticals, running 3 of these trials.
Enrollment posture brief
Registry condition cushings-disease
OPEN 3 | RECR 50% | LATE 2 | EARLY 2 | RANK #2866 | SPON 3
Volume-matched condition peers
Nearest open-share peer: Achalasia (50% recruiting · 8 trials)
Cushing's Disease lists 3 open slots (50% of 6 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Cushing's Disease on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Cushing's Disease is recruiting above its size-band peers.
3 of 6 indexed trials (50%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Cushing's Disease research.
Novartis Pharmaceuticals accounts for 3 of 6 trials (50%). 4 distinct sponsors appear on at least one study for this condition label.
-
Typical Cushing's Disease enrolment sits around 137 participants.
Median target enrolment is 137 among the 6 trials that report a genuine target (sentinel values excluded). 3 of those (50%) plan for fewer than 100 participants.
-
Cushing's Disease research is mostly interventional.
5 interventional and 1 observational studies make up this index (83.3% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
6 total, page 1 of 1
Collecting Information About Treatment Results for Patients With Cushing's Syndrome
Memorial Sloan Kettering Cancer Center
NCT03364803
DDAVP for Pituitary Adenoma
National Institute of Neurological Disorders and Stroke (NINDS)
NCT04569591
A Trial of Lu AG13909 in Adult Participants With Cushing's Disease
H. Lundbeck A/S
NCT06471829
Efficacy and Safety of Pasireotide Administered Monthly in Patients With Cushing's Disease
Novartis Pharmaceuticals
NCT01374906
Safety and Efficacy of LCI699 for the Treatment of Patients With Cushing's Disease
Novartis Pharmaceuticals
NCT02180217
Safety and Efficacy of LCI699 in Cushing's Disease Patients
Novartis Pharmaceuticals
NCT01331239
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 2 |
| Phase 3 | 2 |
Top Sponsors
Named interventions
Most-linked intervention names on Cushing's Disease records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Cushing's Disease trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Cushing's Disease page
6 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 3 Cushing's Disease trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Novartis Pharmaceuticals sponsors the most Cushing's Disease trials on record, review their full trial history before evaluating a specific study. See Novartis Pharmaceuticals's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Cushing's Disease condition card totals 6 registered trials; most-linked intervention SOM230 LAR 10 mg; top US site state Oregon. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.